Sydney tech entrepreneur Paul Conyngham used ChatGPT and Google's AlphaFold AI to design a bespoke mRNA cancer vaccine for his dog Rosie, resulting in dramatic tumor reduction in what researchers call the first personalized cancer vaccine ever made for a dog.

AlphaFold Protein Database reaches 3M+ users globally. New AI tools include AI co-scientist, EarthAI, and AlphaGenome for cancer research and scientific discovery.

Isomorphic Labs launches IsoDDE, an AI drug design engine that more than doubles AlphaFold 3's accuracy in predicting protein-ligand structures and binding affinities.